Allergic Rhinitis and Rhinoconjunctivitis
Clinical research is centered on birch pollen-induced allergic rhinitis and rhinoconjunctivitis, with attention to seasonal allergy symptoms affecting the upper airway and eyes.
- Birch pollen allergy
- Nasal inflammation
- Ocular allergy symptoms
The sponsor’s activity in this area reflects a focused interest in allergen-related respiratory and ocular disease.
Allergen Immunotherapy
Research includes subcutaneous treatment approaches for pollen-driven allergy, with emphasis on modifying the clinical response to birch pollen allergens.
- Subcutaneous administration
- Allergoid-based therapy
- Immune tolerance
This therapeutic domain is closely linked to allergy management in adolescents and adults.
Adolescent and Adult Allergy Care
The funded clinical research addresses adolescent and adult patients with seasonal pollen allergy, covering age groups commonly affected by persistent upper-airway and eye symptoms.
- Adolescent patients
- Adult patients
- Seasonal allergic disease
This area is relevant to the clinical management of environmental allergy across different patient populations.
Multicentre Clinical Allergy Research
The sponsor’s trial activity spans multiple research sites in Europe, supporting clinical investigation in allergy medicine across more than one country.
- Multicentre collaboration
- Cross-border research
- Clinical allergy assessment
This setting is aligned with research into specialist treatment options for pollen-related allergic disease.
